Binder Information
Binder General Information | Top | |||
---|---|---|---|---|
Binder ID |
BPH9A4
|
|||
Binder Name |
Imazodan
|
|||
Synonyms |
6-(4-(1H-imidazol-1-yl)phenyl)-4,5-dihydropyridazin-3(2H)-one; UNII-6PVQ5VQW24; CI 914; Cl 914; 3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one; 6PVQ5VQW24; CHEMBL12831; MFCD00867109; NCGC00015547-02; 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinone; 3(2H)-Pyridazinone, 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-; Imazodan [INN]; Imazodanum [Latin]; Imazodanum; 3(2H)-Pyridazinone, 4,5-dihydro-6-(4-(1H-imidazol-1-yl)phenyl)-; Lopac-I-0782; DSSTox_CID_25160; DSSTox_RID_80710; DSSTox_GSID_45160; Lopac0_000639; MLS000862182; SCHEMBL148436; ZINC1553; Imazodan, >=99% (HPLC); DTXSID1045160; CTK8G0276; HMS2233L24; HMS3261P20; HMS3369I22; KS-000001DA; Tox21_110171; Tox21_500639; BDBM50000315; AKOS027327583; CCG-204726; LP00639; QC-1573; SDCCGSBI-0050619.P002; NCGC00015547-01; NCGC00015547-03; NCGC00015547-04; NCGC00015547-05; NCGC00094006-01; NCGC00094006-02; NCGC00261324-01; AK326183; DS-11856; SMR000326945; DB-056777; EU-0100639; FT-0630925; I 0782; 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-; SR-01000075931; SR-01000075931-1; Q27265291; 6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one; (CI-914)6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one; 6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one(CI-914); 6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one(Imazodan)
Click to Show/Hide
|
|||
Binder Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H12N4O
|
|||
Canonical SMILES |
C1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3
|
|||
InChI |
1S/C13H12N4O/c18-13-6-5-12(15-16-13)10-1-3-11(4-2-10)17-8-7-14-9-17/h1-4,7-9H,5-6H2,(H,16,18)
|
|||
InChIKey |
VXMYWVMXSWJFCV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.